Evidence map›Paper›PMID 30069675›Full record

ArticleMedical & biological engineering & computing2019

Neural network-based model predictive control for type 1 diabetic rats on artificial pancreas system.

Saeid Bahremand, Hoo Sang Ko, Ramin Balouchzadeh, H Felix Lee, Sarah Park, Guim Kwon

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Blood glucose concentration prediction based on VMD-KELM-AdaBoost.Medical & biological engineering & computing · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Saeid BahremandDepartment of Mechanical and Industrial Engineering, Southern Illinois University Edwardsville, Edwardsville, IL, 62026, USA.
Hoo Sang KoDepartment of Mechanical and Industrial Engineering, Southern Illinois University Edwardsville, Edwardsville, IL, 62026, USA. hko@siue.edu.ORCID http://orcid.org/0000-0003-1334-8367
Ramin BalouchzadehDepartment of Mechanical and Industrial Engineering, Southern Illinois University Edwardsville, Edwardsville, IL, 62026, USA.
H Felix LeeDepartment of Mechanical and Industrial Engineering, Southern Illinois University Edwardsville, Edwardsville, IL, 62026, USA.
Sarah ParkResearch and Instructional Services, Duke University, Durham, NC, 27708, USA.
Guim KwonDepartment of Pharmaceutical Sciences, Southern Illinois University Edwardsville, Edwardsville, IL, 62026, USA.
Southern Illinois University Edwardsville · USDuke University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial pancreas system (APS) is a viable option to treat diabetic patients. Researchers, however, have not conclusively determined the best control method for APS. Due to intra-/inter-variability of insulin absorption and action, an individualized algorithm is required to control blood glucose level (BGL) for each patient. To this end, we developed model predictive control (MPC) based on artificial neural networks (ANNs), which combines ANN for BGL prediction based on inputs and MPC for BGL control based on the ANN (NN-MPC). First, we developed a mathematical model for diabetic rats, which was used to identify individual virtual subjects by fitting to empirical data collected through an APS, including BGL data, insulin injection, and food intake. Then, the virtual subjects were used to generate datasets for training ANNs. The NN-MPC determines control actions (insulin injection) based on BGL predicted by the ANN. To evaluate the NN-MPC, we conducted experiments using four virtual subjects under three different scenarios. Overall, the NN-MPC maintained BGL within the normal range about 90% of the time with a mean absolute deviation of 4.7 mg/dl from a desired BGL. Our findings suggest that the NN-MPC can provide subject-specific BGL control in conjunction with a closed-loop APS. Graphical abstract ᅟ.

Indexed as

Neural Networks, ComputerPancreas, ArtificialAnimalsBlood GlucoseDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1InsulinRats, Sprague-DawleyBlood GlucoseInsulinArtificial neural networkArtificial pancreas systemBlood glucose level controlModel predictive controlType 1 diabetes mellitus

Identifiers

PMID30069675
OpenAlexW2887780612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.